OBJECTIVE: To explore the challenges of recruiting ovarian cancer patients and healthy controls to a cancer biobanking study. STUDY DESIGN AND SETTING: The study was set up in gynecological cancer centers in 10 National Health Service trusts across the United Kingdom. Women were approached if they were undergoing investigations/awaiting treatment for ovarian cancer, had a previous diagnosis of ovarian cancer, or were attending for annual screening in an ovarian cancer screening trial. Those who consented completed a detailed epidemiologic questionnaire, provided blood and tissue samples if appropriate. RESULTS: The overall proportion of those recruited compared with the expected targets was 76.4% for healthy controls, 86.0% for old cases, and 46.9% for new cases. Only 4 of 10 (40%) centers recruited over 50% of their target for new cases. Unwillingness to participate was reported as primarily because of patients being too unwell, wanting to focus only on their treatment, or having insufficient time because of conflicting medical appointments. Concerns about use of personal data or tissue and blood samples for genetic research and lack of direct benefit were reported as significant challenges to recruitment. CONCLUSION: When setting recruitment targets for patients undergoing investigations or awaiting treatment for cancer (new cases), it is important to consider lower response rates because of various patient, logistical, and trial-specific challenges.
OBJECTIVE: To explore the challenges of recruiting ovarian cancer patients and healthy controls to a cancer biobanking study. STUDY DESIGN AND SETTING: The study was set up in gynecological cancer centers in 10 National Health Service trusts across the United Kingdom. Women were approached if they were undergoing investigations/awaiting treatment for ovarian cancer, had a previous diagnosis of ovarian cancer, or were attending for annual screening in an ovarian cancer screening trial. Those who consented completed a detailed epidemiologic questionnaire, provided blood and tissue samples if appropriate. RESULTS: The overall proportion of those recruited compared with the expected targets was 76.4% for healthy controls, 86.0% for old cases, and 46.9% for new cases. Only 4 of 10 (40%) centers recruited over 50% of their target for new cases. Unwillingness to participate was reported as primarily because of patients being too unwell, wanting to focus only on their treatment, or having insufficient time because of conflicting medical appointments. Concerns about use of personal data or tissue and blood samples for genetic research and lack of direct benefit were reported as significant challenges to recruitment. CONCLUSION: When setting recruitment targets for patients undergoing investigations or awaiting treatment for cancer (new cases), it is important to consider lower response rates because of various patient, logistical, and trial-specific challenges.
Authors: Martin Köbel; Steve E Kalloger; Sandra Lee; Máire A Duggan; Linda E Kelemen; Leah Prentice; Kimberly R Kalli; Brooke L Fridley; Daniel W Visscher; Gary L Keeney; Robert A Vierkant; Julie M Cunningham; Christine Chow; Roberta B Ness; Kirsten Moysich; Robert Edwards; Francesmary Modugno; Clareann Bunker; Eva L Wozniak; Elizabeth Benjamin; Simon A Gayther; Aleksandra Gentry-Maharaj; Usha Menon; C Blake Gilks; David G Huntsman; Susan J Ramus; Ellen L Goode Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-07-23 Impact factor: 4.254
Authors: Rachael T Leon Guerrero; Grazyna Badowski; Alisha Yamanaka; Michelle Blas-Laguana; Renata Bordallo; Arielle Buyum; Lynne Wilkens; Rachel Novotny Journal: Hawaii J Med Public Health Date: 2014-10
Authors: Camilla Praestegaard; Allan Jensen; Signe M Jensen; Thor S S Nielsen; Penelope M Webb; Christina M Nagle; Anna DeFazio; Estrid Høgdall; Mary Anne Rossing; Jennifer A Doherty; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Roberta B Ness; Robert Edwards; Keitaro Matsuo; Satoyo Hosono; Ellen L Goode; Stacey J Winham; Brooke L Fridley; Daniel W Cramer; Kathryn L Terry; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Lisa E Paddock; Leon F Massuger; Nicolas Wentzensen; Paul Pharoah; Honglin Song; Alice Whittemore; Valerie McGuire; Weiva Sieh; Joseph Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Alexandra Gentry-Maharaj; Anna H Wu; Celeste L Pearce; Malcolm Pike; Alice W Lee; Rebecca Sutphen; Jenny Chang-Claude; Harvey A Risch; Susanne K Kjaer Journal: Int J Cancer Date: 2017-01-24 Impact factor: 7.396
Authors: Francesmary Modugno; Zhuxuan Fu; Susan J Jordan; Aocs Group; Jenny Chang-Claude; Renée T Fortner; Marc T Goodman; Kirsten B Moysich; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Bo Qin; Rebecca Sutphen; John R McLaughlin; Usha Menon; Susan J Ramus; Simon A Gayther; Aleksandra Gentry-Maharaj; Chloe Karpinskyj; Celeste L Pearce; Anna H Wu; Harvey A Risch; Penelope M Webb Journal: Eur J Epidemiol Date: 2020-09-21 Impact factor: 8.082
Authors: Catherine M Olsen; Christina M Nagle; David C Whiteman; Roberta Ness; Celeste Leigh Pearce; Malcolm C Pike; Mary Anne Rossing; Kathryn L Terry; Anna H Wu; Harvey A Risch; Herbert Yu; Jennifer A Doherty; Jenny Chang-Claude; Rebecca Hein; Stefan Nickels; Shan Wang-Gohrke; Marc T Goodman; Michael E Carney; Rayna K Matsuno; Galina Lurie; Kirsten Moysich; Susanne K Kjaer; Allan Jensen; Estrid Hogdall; Ellen L Goode; Brooke L Fridley; Robert A Vierkant; Melissa C Larson; Joellen Schildkraut; Cathrine Hoyo; Patricia Moorman; Rachel P Weber; Daniel W Cramer; Allison F Vitonis; Elisa V Bandera; Sara H Olson; Lorna Rodriguez-Rodriguez; Melony King; Louise A Brinton; Hannah Yang; Montserrat Garcia-Closas; Jolanta Lissowska; Hoda Anton-Culver; Argyrios Ziogas; Simon A Gayther; Susan J Ramus; Usha Menon; Aleksandra Gentry-Maharaj; Penelope M Webb Journal: Endocr Relat Cancer Date: 2013-03-22 Impact factor: 5.678
Authors: Camilla Præstegaard; Susanne K Kjaer; Thor S S Nielsen; Signe M Jensen; Penelope M Webb; Christina M Nagle; Estrid Høgdall; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten Moysich; Roberta B Ness; Robert P Edwards; Ellen L Goode; Stacey J Winham; Brooke L Fridley; Daniel W Cramer; Kathryn L Terry; Joellen M Schildkraut; Andrew Berchuck; Elisa V Bandera; Lisa Paddock; Lambertus A Kiemeney; Leon F Massuger; Nicolas Wentzensen; Paul Pharoah; Honglin Song; Alice S Whittemore; Valerie McGuire; Weiva Sieh; Joseph Rothstein; Hoda Anton-Culver; Argyrios Ziogas; Usha Menon; Simon A Gayther; Susan J Ramus; Aleksandra Gentry-Maharaj; Anna H Wu; Celeste L Pearce; Malcolm C Pike; Alice W Lee; Jenny Chang-Claude; Allan Jensen Journal: Cancer Epidemiol Date: 2016-02-03 Impact factor: 2.984
Authors: Gang Liu; Bhramar Mukherjee; Seunggeun Lee; Alice W Lee; Anna H Wu; Elisa V Bandera; Allan Jensen; Mary Anne Rossing; Kirsten B Moysich; Jenny Chang-Claude; Jennifer A Doherty; Aleksandra Gentry-Maharaj; Lambertus Kiemeney; Simon A Gayther; Francesmary Modugno; Leon Massuger; Ellen L Goode; Brooke L Fridley; Kathryn L Terry; Daniel W Cramer; Susan J Ramus; Hoda Anton-Culver; Argyrios Ziogas; Jonathan P Tyrer; Joellen M Schildkraut; Susanne K Kjaer; Penelope M Webb; Roberta B Ness; Usha Menon; Andrew Berchuck; Paul D Pharoah; Harvey Risch; Celeste Leigh Pearce Journal: Am J Epidemiol Date: 2018-02-01 Impact factor: 4.897
Authors: Joseph L Usset; Rama Raghavan; Jonathan P Tyrer; Valerie McGuire; Weiva Sieh; Penelope Webb; Jenny Chang-Claude; Anja Rudolph; Hoda Anton-Culver; Andrew Berchuck; Louise Brinton; Julie M Cunningham; Anna DeFazio; Jennifer A Doherty; Robert P Edwards; Simon A Gayther; Aleksandra Gentry-Maharaj; Marc T Goodman; Estrid Høgdall; Allan Jensen; Sharon E Johnatty; Lambertus A Kiemeney; Susanne K Kjaer; Melissa C Larson; Galina Lurie; Leon Massuger; Usha Menon; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Malcolm C Pike; Susan J Ramus; Mary Anne Rossing; Joseph Rothstein; Honglin Song; Pamela J Thompson; David J van den Berg; Robert A Vierkant; Shan Wang-Gohrke; Nicolas Wentzensen; Alice S Whittemore; Lynne R Wilkens; Anna H Wu; Hannah Yang; Celeste Leigh Pearce; Joellen M Schildkraut; Paul Pharoah; Ellen L Goode; Brooke L Fridley Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-03-14 Impact factor: 4.254
Authors: Alice W Lee; Ashley Bomkamp; Elisa V Bandera; Allan Jensen; Susan J Ramus; Marc T Goodman; Mary Anne Rossing; Francesmary Modugno; Kirsten B Moysich; Jenny Chang-Claude; Anja Rudolph; Aleksandra Gentry-Maharaj; Kathryn L Terry; Simon A Gayther; Daniel W Cramer; Jennifer A Doherty; Joellen M Schildkraut; Susanne K Kjaer; Roberta B Ness; Usha Menon; Andrew Berchuck; Bhramar Mukherjee; Lynda Roman; Paul D Pharoah; Georgia Chenevix-Trench; Sara Olson; Estrid Hogdall; Anna H Wu; Malcolm C Pike; Daniel O Stram; Celeste Leigh Pearce Journal: Int J Cancer Date: 2016-09-16 Impact factor: 7.396